MedicaidPrior AuthMedium impact
mab2024111203
Pennsylvania Medicaid (DHS)·PA · Cardiology, Endocrinology, Family Medicine +2 more·Provider Bulletin
Effective date
Jan 6, 2025
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid is implementing updated prior authorization requirements for lipotropic medications (cholesterol-lowering drugs) including PCSK9 inhibitors, ACL inhibitors, and others. The policy removes some previous guidelines while maintaining strict criteria for approval including failure of standard treatments and specific clinical documentation requirements.
Action Required
Before January 6, 2025: Billing team must update prior authorization procedures for lipotropic medications for Pennsylvania Medicaid patients. Ensure providers document lipid profiles within 3 months, statin treatment failures, and specific clinical criteria for PCSK9 and ACL inhibitors. Update encounter forms to capture required documentation elements. Claims without proper prior authorization will be denied.